Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX002293-01A2 |
| Title: | Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease |
| Principal Investigator: | Elizabeth C. Vaughan |
| Location: | Decatur, GA |
| Congressional District Code: | 4 |
| Research Service: | Rehabilitation R&D |
| Project Period: | April 2018 - March 2023 |
| FY 2021 Funding Amount: | $166,185 |
| Total Award Amount (all years): |
$1,130,304 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: The number of persons with Parkinson Disease (PD) in the United States is expected to double by 2030 as the population ages. Importantly, this increase in the prevalence of PD will have greater impact within the Department of Veterans Affairs (VA) because the Veteran population is older than the general population and Veterans with PD are more likely than those without PD to rely solely on VA for their health care. While PD is often characterized by the motor symptoms of the disease (tremor, bra... |